These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

342 related items for PubMed ID: 17466452

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term haloperidol treatment (but not risperidone) enhances addiction-related behaviors in mice: role of dopamine D2 receptors.
    Carvalho RC, Fukushiro DF, Helfer DC, Callegaro-Filho D, Trombin TF, Zanlorenci LH, Sanday L, Silva RH, Frussa-Filho R.
    Addict Biol; 2009 Jul; 14(3):283-93. PubMed ID: 19298320
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
    Pereira FC, Lourenço ES, Borges F, Morgadinho T, Ribeiro CF, Macedo TR, Ali SF.
    Synapse; 2006 Sep 01; 60(3):185-93. PubMed ID: 16739116
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T, Duffy L, O'brien E, Matsumoto I, Dedova I.
    Behav Brain Res; 2006 Aug 10; 171(2):286-94. PubMed ID: 16697060
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects.
    Han M, Huang XF, Deng C.
    Int J Neuropsychopharmacol; 2009 Aug 10; 12(7):941-52. PubMed ID: 19203411
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain.
    Mahadik SP, Mukherjee S.
    Biol Psychiatry; 1995 Aug 15; 38(4):246-54. PubMed ID: 8547447
    [Abstract] [Full Text] [Related]

  • 18. Dopaminergic synapses in the matrix of the ventrolateral striatum after chronic haloperidol treatment.
    Roberts RC, Force M, Kung L.
    Synapse; 2002 Aug 15; 45(2):78-85. PubMed ID: 12112400
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M, Gale K.
    J Pharmacol Exp Ther; 1981 Apr 15; 217(1):177-80. PubMed ID: 6110774
    [Abstract] [Full Text] [Related]

  • 20. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
    Zivkovic B, Guidotti A, Revuelta A, Costa E.
    J Pharmacol Exp Ther; 1975 Jul 15; 194(1):37-46. PubMed ID: 239221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.